Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03771651 · ClinicalTrials.gov registry record · Early Phase 1
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
A Early Phase 1 study of Fallopian Tube Cancer and Fallopian Tube Infection, sponsored by University of Oklahoma.
- Active
- Registry status
- Early Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT03771651: Active Early Phase 1 study of Fallopian Tube Cancer and Fallopian Tube Infection, sponsored by University of Oklahoma.
NCT03771651 is a Early Phase 1 study of Fallopian Tube Cancer and Fallopian Tube Infection that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 18 participants, below the 256-participant average among 85 other Fallopian Tube Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03771651, a Early Phase 1 study of Fallopian Tube Cancer and Fallopian Tube Infection, is active but no longer recruiting, sponsored by University of Oklahoma.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the impact of low dose aspirin on normal fallopian tube fimbriae in women who have surgery to have their fallopian tubes removed. Participants will take a low dose of aspirin for 2 weeks before their surgery. A portion of the removed fallopian tubes will also be collected for future research and routine pathology purposes.
Primary Outcome
Immuno-cellular assays and percentages of specific immune cells will be compared to control tissue samples.
Conditions Studied
Interventions
- DRUG Aspirin 81 mg
Study Locations (1)
Oklahoma
- Stephenson Cancer Center, University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
What the registry record for NCT03771651 still lists
NCT03771651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 256-participant average among 85 other Fallopian Tube Cancer trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Fallopian Tube Cancer appearing as the primary indexed condition, and to 1 intervention - of which Aspirin 81 mg is the first listed.
NCT03771651 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03771651 about?
NCT03771651 is a clinical study titled "Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube". This study will evaluate the impact of low dose aspirin on normal fallopian tube fimbriae in women who have surgery to have their fallopian tubes removed. Participants will take a low dose of aspirin for 2 weeks before their surgery. A portion of the removed fallopian tubes will also be collected fo...
What is the current status of trial NCT03771651?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2019-03-01. Estimated completion is 2026-12.
What conditions does trial NCT03771651 study?
This clinical trial studies the following conditions: Fallopian Tube Cancer, Fallopian Tube Infection.
What interventions are being tested in trial NCT03771651?
The interventions under investigation include: Aspirin 81 mg (DRUG).
Who is sponsoring clinical trial NCT03771651?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03771651 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fallopian Tube Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03771651's enrollment target sits among peer trials
18 78th of 85 higher than 6 of 85 other Fallopian Tube Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fallopian Tube Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using Aspirin to Improve Immunological Features of Ovarian Tumors
RECRUITING · Early Phase 1
-
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
COMPLETED · Early Phase 1
-
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
COMPLETED · Early Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
RECRUITING · Phase 2
-
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI